HomeFileStructural heart disease

Structural heart disease

Use of Apixaban and Post TAVR Valve Thrombosis

TAVR can be associated to early valve thrombosis, characterized by thrombi formation near or attached to the...

Use of Intravascular Lithotripsy vs. Rotational Atherectomy for Severely Calcified Coronary Lesions

Severely calcified coronary stenosis poses a significant challenge for coronary angioplasty procedures. Modifying plaque before stenting is...

TricValve: 12-Month Evolution

Tricuspid regurgitation has become increasingly common, and current pharmacological treatment options are limited. In turn, surgery, which...

Health Status Scores after Transcatheter Repair in Patients with Tricuspid Regurgitation: TRILUMINATE Analysis

Severe tricuspid regurgitation (TR) has been associated with higher mortality and significant limitations to patient quality of...

Carotid Stenosis and TAVR

Aortic Stenosis affects over 5% of the population over 65.  Even though TAVR has advanced in the treatment...

ACURATE Neo2: One-Year Hemodynamic and Clinical Benefit Results

Both Acurate Neo2 and its predecessor, Acurate Neo, have proven their safety and efficacy in the percutaneous...

Evolution of Bicuspid Valves at 12 Months

Severe aortic stenosis due to a bicuspid aortic valve (BAV) is uncommon, especially in individuals under 65...

TAVR: High Implantation of Self-Expanding Valves Directly Impacts ECG

TAVR has been shown beneficial, especially in high risk or inoperable patients. However, there are limitations to...